Drug marketing largely left alone in House PDUFA hearings

02/7/2012

Although several entities have called for drug marketing restrictions or greater regulation of direct-to-consumer drug ads to be included in the Prescription Drug User Fee Act V (PDUFA V), there was just one mention of drug marketing during four-plus hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health at a Feb. 1 PDUFA V hearing. However, industry should not be lulled into thinking that these issues will not re-emerge as negotiations continue, according to Coalition for Healthcare Communication Executive Director John Kamp, who said “we’re watching carefully and remain prepared for a challenge.” Read more.

View Full Article in:

http://www.cohealthcom.org/2012/02/02/house-health-subcommittee-pdufa-v-hearing-...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health